LEPONEX

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Croatia, Israel, Italy, Lithuania, Mexico, Nigeria, Netherlands, Poland, Romania, Tunisia, Turkey, South Africa

Active ingredients

The drug LEPONEX contains one active pharmaceutical ingredient (API):

1 Clozapine UNII J60AR2IKIC - CLOZAPINE

Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties. Read about Clozapine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AH02	Clozapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 541518080007117, 541518080007217
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00071419, 01328642, 01682177, 02855102, 02855154, 03500708, 03730874, 06485406, 08757027, 08757056, 12452078
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 258-MEE-0414
Country: EE	Ravimiamet	Identifier(s): 1004724, 1004768, 1820180
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59547, 59548
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 030627, 030635, 374918, 453522, 538598
Country: FR	Base de données publique des médicaments	Identifier(s): 62552920, 67513540
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-154629710, HR-H-580979278
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3300, 3301
Country: IT	Agenzia del Farmaco	Identifier(s): 028824035, 028824047
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001176, 1001177, 1082645, 1085682, 1085685, 1090853
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 008M94
Country: NG	Registered Drug Product Database	Identifier(s): 04-1597, 04-7416
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 25429, 25437
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100037187, 100212816
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68785001, W68785002, W68786001, W68786002
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283071, 10283072, 21453011, 21453012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698856010650, 8698856010667
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/2.6/69, F/2.6/70, F/2.6/71